Vystar Corp (VYST)

[steph1971]

“Fluid Energy Conversion has multiple R&D initiatives relating to environmentally friendly product development and distribution that has the potential to revolutionize multiple industries and substantially improve our RxAir air purification systems which we anticipate will catapult it to lead the competition,” stated Steve Rotman, CEO of Vystar. “Vystar anticipates testing of the prototype in the current quarter for Adapting Fluid Energy Conversion technology to enhance the effectiveness of the RxAir purification system to destroy airborne pathogens while decreasing the cost and size of Vystar’s RxAir units. The use of this patented technology is expected be a major differentiator of RxAir from the competition and is anticipated to be virtually impossible to emulate due to the patented IP.